Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications
Glaucoma is a progressive optic neuropathy and a leading cause of irreversible blindness. The disease has conventionally been characterized by an elevated intraocular pressure (IOP); however, recent research has built the consensus that glaucoma is not only dependent on IOP but rather represents a m...
Main Authors: | Aditya Belamkar, Alon Harris, Ryan Zukerman, Brent Siesky, Francesco Oddone, Alice Verticchio Vercellin, Thomas A. Ciulla |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2022-12-01
|
Series: | Annals of Medicine |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/07853890.2021.1955146 |
Similar Items
-
Prevalence Rates and Risk Factors for Primary Open Angle Glaucoma in the Middle East
by: Rana Torabi, et al.
Published: (2021-10-01) -
Artificial Intelligence to Aid Glaucoma Diagnosis and Monitoring: State of the Art and New Directions
by: Roberto Nunez, et al.
Published: (2022-10-01) -
Factors Affecting Glaucoma Medication Adherence and Interventions to Improve Adherence: A Narrative Review
by: Shannan G. Moore, et al.
Published: (2023-09-01) -
Physiology-Enhanced Data Analytics to Evaluate the Effect of Altitude on Intraocular Pressure and Ocular Hemodynamics
by: Alice Verticchio Vercellin, et al.
Published: (2022-03-01) -
Investigation of medication adherence and reasons for poor adherence in patients on long-term glaucoma treatment regimes
by: McClelland JF, et al.
Published: (2019-08-01)